Showing results (281-290 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|June 1, 1991
Neuroendocrine carcinoma of the urinary bladder: case report and review of the literatureN Lertprasertsuke, Y Tsutsumi
Japanese Journal of Clinical Oncology|August 1, 1991
A case of mixed lineage acute non-lymphocytic leukemia with t(5;12)(p13;p13)S Shimizu, Y Tsunematsu, J Fujimoto, et al.
Japanese Journal of Clinical Oncology|August 4, 2009
Narrow band imaging videobronchoscopy improves assessment of lung cancer extension and influences therapeutic strategyBojan Zaric, Heinrich D Becker, Branislav Perin, et al.
Japanese Journal of Clinical Oncology|May 12, 2009
Vertebral metastases with high risk of symptomatic malignant spinal cord compressionYasushi Hamamoto, Masaaki Kataoka, Takatoshi Senba, et al.
Japanese Journal of Clinical Oncology|September 29, 2009
Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumorsIsamu Okamoto, Toshihiko Doi, Atsushi Ohtsu, et al.
Japanese Journal of Clinical Oncology|October 3, 2009
Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomasCe Liu, Gang Tian, Yanyang Tu, et al.
Japanese Journal of Clinical Oncology|September 24, 2009
Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experienceToshiaki Tanaka, Hiroshi Kitamura, Atsushi Takahashi, et al.
Japanese Journal of Clinical Oncology|September 24, 2009
A phase II study of irinotecan and capecitabine for patients with unresectable liver-only metastases from colorectal cancerRen Zhao, Jianwei Zhu, Xiaopin Ji, et al.
Japanese Journal of Clinical Oncology|September 25, 2009
Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatmentYasuhiro Suzuki, Yutaka Tokuda, Yasuhiro Fujiwara, et al.
Japanese Journal of Clinical Oncology|September 8, 2009
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study)Toru Kono, Hideyuki Mishima, Mitsuo Shimada, et al.
Pageof 534